Search

Accessing new eye therapies, protecting vision, improving patients' comfort, developing breaktrough treatments

Home

You are here : Home

Novagali Pharma - Accessing new eye Therapies

Novagali Pharma is an emerging ophthalmic pharmaceutical company that develops innovative products for all segments of the eye.

The company has developed a broad pipeline of innovative products addressing main ocular conditions as well as orphan diseases, thanks to its proprietary technology platforms Novasorb® and Eyeject®.

Press release

EVRY- January 18, 2008 – Novagali Pharma Announces FDA Clearance of IND for US Clinical Trial of Nova63035 in patients with Diabetic Macular Edema
 

Read more

Novagali Pharma - Agenda

L’image “http://www.kenes.com/isopt/images/new_logo_top_strip.jpg” ne peut être affichée car elle contient des erreurs.


Novagali Pharma will attend ARVO 2008 (Association for Research in Vision and Ophthalmology) in Fort Lauderdale, FL, USA
April 27-30, 2008

 

http://www.arvo.org/

Feel free to join us on our booth.

Read more

Accessibility Focus

Our commitment to make our site accessible to anyone is based on the WCAG standards. Would you have any suggestion or request do not hesitate to contact us: Make a suggestion.

Choose your language